Literature DB >> 17970926

Productivity costs associated with cardiometabolic risk factor clusters in the United States.

Patrick W Sullivan1, Vahram Ghushchyan, Holly R Wyatt, Eric Q Wu, James O Hill.   

Abstract

OBJECTIVE: Cardiometabolic risk factors such as overweight/obesity, hyperlipidemia, diabetes, and hypertension are prone to cluster together in the same individual and result in an elevated risk of cardiovascular disease and mortality. The purpose of this study was to examine and quantify the impact of cardiometabolic risk factor clusters independent of heart disease on productivity in a nationally representative sample of US adults.
METHODS: The current study estimated the impact of cardiometabolic risk factor clusters on missed work days and bed days, controlling for sociodemographic characteristics, comorbidity, and smoking status in a nationally representative, pooled 2000 and 2002 Medical Expenditure Panel Survey sample. Cardiometabolic risk factor clusters included BMI >or= 25 and two of the following three: diabetes, hyperlipidemia, and/or hypertension. All estimates were expressedin $US 2005. Sensitivity analyses were conducted to examine the impact of varying assumptions on the results.
RESULTS: After controlling for differences in sociodemographics, smoking and comorbidity, individuals with cardiometabolic risk factor clusters missed 179% more work days and spent 147% more days in bed (in addition to lost work days) than those without. Lost work days and bed days resulted in $17.3 billion annually in lost productivity attributable to cardiometabolic risk factor clusters in the United States. Sensitivity analyses resulted in a range of annual lost productivity costs from $3.2 to $23.1 billion.
CONCLUSIONS: Common cardiometabolic risk factor clusters have a significant deleterious impact on the US economy, resulting in $17.3 billion in lost productivity.

Entities:  

Mesh:

Year:  2007        PMID: 17970926     DOI: 10.1111/j.1524-4733.2007.00199.x

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  16 in total

1.  Obesity-insulin targeted genes in the 3p26-25 region in human studies and LG/J and SM/J mice.

Authors:  Aldi T Kraja; Heather A Lawson; Donna K Arnett; Ingrid B Borecki; Ulrich Broeckel; Lisa de las Fuentes; Steven C Hunt; Michael A Province; James Cheverud; D C Rao
Journal:  Metabolism       Date:  2012-03-03       Impact factor: 8.694

2.  Economic burden of cancer survivorship among adults in the United States.

Authors:  Gery P Guy; Donatus U Ekwueme; K Robin Yabroff; Emily C Dowling; Chunyu Li; Juan L Rodriguez; Janet S de Moor; Katherine S Virgo
Journal:  J Clin Oncol       Date:  2013-09-16       Impact factor: 44.544

3.  Food insecurity and dietary intake by Supplemental Nutrition Assistance Program participation status among mainland US Puerto Rican adults after the 2009 American Recovery and Reinvestment Act.

Authors:  Amanda C McClain; Katherine L Tucker; Luis M Falcón; Josiemer Mattei
Journal:  Public Health Nutr       Date:  2019-08-09       Impact factor: 4.022

4.  Psychological factors are important correlates of dietary pattern in overweight adults.

Authors:  Daurice A Grossniklaus; Sandra B Dunbar; Beth C Tohill; Rebecca Gary; Melinda K Higgins; Jennifer Frediani
Journal:  J Cardiovasc Nurs       Date:  2010 Nov-Dec       Impact factor: 2.083

5.  Healthcare costs and obesity prevention: drug costs and other sector-specific consequences.

Authors:  David R Rappange; Werner B F Brouwer; Rudolf T Hoogenveen; Pieter H M Van Baal
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

6.  Effect of cardiometabolic risk factors on hypertension management: a cross-sectional study among 28 physician practices in the United States.

Authors:  Daniel A Belletti; Christopher Zacker; Jenifer Wogen
Journal:  Cardiovasc Diabetol       Date:  2010-02-01       Impact factor: 9.951

7.  Estimating the health and economic burden of cancer among those diagnosed as adolescents and young adults.

Authors:  Gery P Guy; K Robin Yabroff; Donatus U Ekwueme; Ashley Wilder Smith; Emily C Dowling; Ruth Rechis; Stephanie Nutt; Lisa C Richardson
Journal:  Health Aff (Millwood)       Date:  2014-06       Impact factor: 6.301

8.  Prevalence of the metabolic syndrome among U.S. workers.

Authors:  Evelyn P Davila; Hermes Florez; Lora E Fleming; David J Lee; Elizabeth Goodman; William G LeBlanc; Alberto J Caban-Martinez; Kristopher L Arheart; Kathryn E McCollister; Sharon L Christ; John C Clark; Tainya Clarke
Journal:  Diabetes Care       Date:  2010-06-28       Impact factor: 17.152

9.  Assessing forgetfulness and polypharmacy and their impact on health-related quality of life among patients with hypertension and dyslipidemia in Greece during the COVID-19 pandemic.

Authors:  Kyriakos Souliotis; Theodoros V Giannouchos; Chistina Golna; Evangelos Liberopoulos
Journal:  Qual Life Res       Date:  2021-06-22       Impact factor: 3.440

10.  Real-world outcomes of US employees with type 2 diabetes mellitus treated with insulin glargine or neutral protamine Hagedorn insulin: a comparative retrospective database study.

Authors:  Li Wang; Wenhui Wei; Raymond Miao; Lin Xie; Onur Baser
Journal:  BMJ Open       Date:  2013-04-30       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.